WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 10'4001 Infant (under 12 months) mortality rate: 72
GDP / capita (US$): 23'2981 Child (under 5 years) mortality rate: 82

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 29'717  29'240  28'759  28'276  27'790  23'421  18'211  13'834 
Births 525  516  507  499  491  529  514  408 
Surviving infants 523  514  505  497  489  525  507  398 
Pop. less than 5 years 2'499  2'425  2'392  2'427  2'433  2'721  2'446  1'867 
Pop. less than 15 years 7'758  7'752  7'769  7'828  7'837  7'803  6'756  5'394 
Female 15-49 years 8'653  8'519  8'368  8'190  8'001  6'220  4'621  3'458 

Number of reported case

(Click for retrospective incidence data for Malaysia)
Diphtheria 131 
Japanese encephalitis 12  22  12 
Measles 195  1'868  1'569  73  153  6'187  563  8'727 
Mumps
Pertussis 222  217  248  41  42  24  97 
Polio*
Rubella 1'138  789  374  104 
Rubella (CRS)
Tetanus (neonatal) 10  20  11  60 
Tetanus (total) 32  34  11  28  19  40  30  60 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Malaysia)
Vaccine year result method % card seen                                                
BCG          99  99  99  98  98  100  99  94 
DTP1          97  95  95  95  95  95  95 
DTP3          97  99  95  95  95  95  90  67 
HepB_BD          87  95  95  95  92 
HepB3          96  98  95  95  95  94  86 
Hib3          97  99  95  95  95 
JapEnc          98  97  96  95 
MCV          95  95  95  95  95  88  70 
MCV2          99  99  95  95  95 
PCV1         
PCV3         
Pol3          97  100  95  95  95  95  90  67 
Rota1         
Rota_last         
Rubella1          95  95  95  95 
TT2plus          90  90  80  75  77  89  82  22 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Malaysia)
BCG 99  99  99  99  99  99  99  94 
DTP1 99  99  98  98  99  99  95  86 
DTP3 97  97  96  96  97  98  90  67 
HepB3 96  97  96  96  96  97  86 
HepB_BD 87  91  95  95  95  92 
Hib3 97  99  95  95  95 
MCV 95  95  95  95  95  96  70 
MCV2 99  99  95  95  95 
PAB 90  90  90  87  87  88  82  20 
PnC3
Pol3 97  97  96  96  97  98  90  67 
Rota_last

Number of districts in the country 142  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 70
From 80 to 89% 21
From 50 to 79% 9
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 7 years; Yes
DTaPHibIPV 2, 3, 5, 18 months; Yes
HPV 13 years; +1, +6 months; Yes Girls only
HepB birth; 1, 6 months; Yes and HCWs
JapEnc 9, 10, 18 months; 5, 8, 11 years; No 9 and 12 months for the live attenuated vaccine
MMR 1 year; Yes
MR Yes School based
Measles 6 months; 7 years; No
MenACWY No Haj Pilgrims
OPV 7 years; Yes
TT 15 years; Yes school based and pregnant women
Typhoid No food handlers
YF No travelers to endemic countries

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  No  Yes 
What years does the MYP cover? number             2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 142  142        139  139 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 142  142  141  141  139  139  139 
Nº districts with DTP3 coverage >=80% number 129  131  125  128  120  136  13 
% of districts with DTP3 coverage >=80% From 0 to 100% 91  92  89  91  86  98 
Nº districts with measles (MCV1) coverage >=95% number 67  94  72  70  72  94   
% of districts with MCV1 coverage >=95% From 0 to 100% 47  66  51  50  52  68   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%     80  80  80  80  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.